Sironax
PrivateLast Round
Series B
Aug 2, 2022
Total Funding Raised
$200M
Company Overview
Sironax is a pharmaceutical company focused on developing innovative treatments for inflammatory and neurodegenerative diseases through research on apoptosis and other cell death pathways.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sironax Comps
Public and private peers based on sector, stage, and business model.
Sironax Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 2, 2022 | ||||
| Series A | Jul 1, 2019 |
Sironax Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longriver Investment Partners | Series B |
| Temasek | Series A, Series B |
| MSA Capital | Series B |
| F-Prime Capital | Series A, Series B |
| Eight Roads Ventures | Series B |
| CBC Group | Series B |
| Invus Opportunities | Series B |
Sironax Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sironax's valuation, stock price, and market status.
